TY - JOUR
T1 - Duration of carbapenemase-producing Enterobacteriales carriage among ICU patients in Miami, FL
T2 - A retrospective cohort study
AU - Jimenez, Adriana
AU - Fennie, Kristopher
AU - Munoz-Price, L. Silvia
AU - Ibrahimou, Boubakari
AU - Pekovic, Vukosava
AU - Abbo, Lilian M.
AU - Martinez, Octavio
AU - Rosello, Gemma
AU - Sposato, Kathleen
AU - Doi, Yohei
AU - Trepka, Mary Jo
N1 - Publisher Copyright:
© 2021 Association for Professionals in Infection Control and Epidemiology, Inc.
PY - 2021/10
Y1 - 2021/10
N2 - Background: Current recommendations by the Centers for Disease Control and Prevention suggest placing patients with carbapenem-producing Enterobacteriales (CPE) in contact precautions, but there is no consensus on the appropriate duration of precautions. Aim: We aimed to evaluate predictors for prolonged CPE carriage and median clearance time. Methods: Patients with first isolated CPE identified from 2012-2016 were followed for clearance of CPE using at least two rectal or tracheal aspirate surveillance cultures and clinical cultures during intensive-care-unit admission. Predictors associated with prolonged CPE carriage were assessed using Cox proportional-hazards. Results: Out of 75 eligible patients, 25 (33%) cleared their CPE-carrier status; median time to clearance was 80 days (Range, 16-457). Patients who were immunocompromised, had mechanical ventilation exposure, or exposure to carbapenems had 66%, 66%, and 86% (HR, 0.34, 0.34, and 0.14, respectively [P-value <.05]) lower probability of clearing compared to those immunocompetent of without such exposures. Patients with CPE isolated from more than one body site had a 5.3 times higher probability of clearing their CPE-carrier status (P-value <.001). Conclusions: Patients immunocompromised, with mechanical ventilation exposure, or exposure to carbapenems had higher risk for prolonged CPE carriage. Infection prevention programs should consider these predictors as part of their assessment of discontinuing contact precautions among CPE carriers to prevent horizontal transmission and outbreaks within healthcare facilities.
AB - Background: Current recommendations by the Centers for Disease Control and Prevention suggest placing patients with carbapenem-producing Enterobacteriales (CPE) in contact precautions, but there is no consensus on the appropriate duration of precautions. Aim: We aimed to evaluate predictors for prolonged CPE carriage and median clearance time. Methods: Patients with first isolated CPE identified from 2012-2016 were followed for clearance of CPE using at least two rectal or tracheal aspirate surveillance cultures and clinical cultures during intensive-care-unit admission. Predictors associated with prolonged CPE carriage were assessed using Cox proportional-hazards. Results: Out of 75 eligible patients, 25 (33%) cleared their CPE-carrier status; median time to clearance was 80 days (Range, 16-457). Patients who were immunocompromised, had mechanical ventilation exposure, or exposure to carbapenems had 66%, 66%, and 86% (HR, 0.34, 0.34, and 0.14, respectively [P-value <.05]) lower probability of clearing compared to those immunocompetent of without such exposures. Patients with CPE isolated from more than one body site had a 5.3 times higher probability of clearing their CPE-carrier status (P-value <.001). Conclusions: Patients immunocompromised, with mechanical ventilation exposure, or exposure to carbapenems had higher risk for prolonged CPE carriage. Infection prevention programs should consider these predictors as part of their assessment of discontinuing contact precautions among CPE carriers to prevent horizontal transmission and outbreaks within healthcare facilities.
UR - http://www.scopus.com/inward/record.url?scp=85111050222&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=85111050222&partnerID=8YFLogxK
U2 - 10.1016/j.ajic.2021.06.006
DO - 10.1016/j.ajic.2021.06.006
M3 - Article
C2 - 34146625
AN - SCOPUS:85111050222
SN - 0196-6553
VL - 49
SP - 1281
EP - 1286
JO - American Journal of Infection Control
JF - American Journal of Infection Control
IS - 10
ER -